ArticleClinical and experimental hepatology2025
Thromboelastography-guided assessment of coagulation in decompensated liver cirrhosis for the evaluation of blood component transfusions.
Article in Clinical and experimental hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Precision in Complexity: A Protocol-Driven Quantitative Anatomic Strategy for Giant Olfactory Groove Meningioma Resection in a High-Risk Geriatric Patient.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim of the study: The primary objective of this study was to assess the impact of thromboelastography (TEG) on the decision-making process of gastroenterologists and hepatologists regarding blood component (BC) transfusions in patients with decompensated cirrhosis before invasive manipulations. Material and methods: This study was a prospective, single-center, randomized controlled trial. Throughout the trial, the decision-making process was not actively influenced. However, TEG results were made available to the physicians, offering recommendations regarding the need for specific BC transfusions. To assess whether the availability of TEG data influences clinical decision-making, a subsequent statistical analysis was conducted. Results: After application of exclusion criteria, 20 patients were enrolled in the study. The results showed that in the TEG group, the need for BC transfusions was 20% lower than in the control group, although this difference was not statistically significant ( Conclusions: In settings where nearly all physicians were familiar with the concept of hemostatic changes in liver cirrhosis, TEG was estimated to reduce transfusion requirements by 20%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.